# Targeting Inflammation for Endometrial Cancer Prevention

> **NCT05407025** · — · ACTIVE_NOT_RECRUITING · sponsor: **Mayo Clinic** · enrollment: 191 (actual)

## Conditions studied

- Endometrial Carcinoma

## Interventions

- **PROCEDURE:** Biospecimen Collection
- **OTHER:** Questionnaire Administration

## Key facts

- **NCT ID:** NCT05407025
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-12-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 191 (ACTUAL)
- **Last updated:** 2025-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05407025

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05407025, "Targeting Inflammation for Endometrial Cancer Prevention". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT05407025. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*